News from NORD

PSC Partners Seeking a Cure Surpasses 1,000 Patients in International Registry … and Makes an Unexpected Finding Regarding Misdiagnosis


 

PSC Partners Seeking a Cure, a nonprofit organization providing education, support, and research on behalf of those affected by primary sclerosing cholangitis (PSC), has recruited more than 1,000 patients for the international patient registry for those with this rare condition. The registry is designed to be a resource for researchers who are working to develop much-needed therapies for PSC since the disease currently has no effective treatment.

An unexpected result of the registry enrollment process is that some patients who tried to enroll learned, after answering a series of questions about their diagnosis and symptoms, that they do not actually have PSC. Instead, they have primary biliary cholangitis (PBC), a distinctly different disease that also affects the bile ducts.

This misdiagnosis is significant because effective treatment exists for PBC and patients who had been misdiagnosed with PSC may have been missing out on treatment that would slow the progression of their disease.

Recommended Reading

Eribulin superior to dacarbazine in advanced liposarcoma
MDedge Hematology and Oncology
Join the National Organization for Rare Disorders and the University of Massachusetts for Two Upcoming CME-Accredited Events
MDedge Hematology and Oncology
Rare Disease Film Festival Is Planned
MDedge Hematology and Oncology
NORD Outlines Recommendations for Health Care Reform in Letter to Congressional Leadership
MDedge Hematology and Oncology
Alport Syndrome Research Funding Is Awarded
MDedge Hematology and Oncology
Aplastic Anemia and MDS International Foundation Plans Regional Patient/Family Conference
MDedge Hematology and Oncology
Global CMTC/OVM Conference to Take Place in The Netherlands
MDedge Hematology and Oncology
Conan O’Brien to Host Congenital Hyperinsulinism International Event
MDedge Hematology and Oncology
CurePSP International Research Symposium to Take Place in San Francisco
MDedge Hematology and Oncology
Foundation Fighting Blindness Opens USH2A Natural History Study
MDedge Hematology and Oncology